Cite
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach.
MLA
Wang, Liu, et al. “Fused Heterocycles Bearing Bridgehead Nitrogen as Potent HIV-1 NNRTIs. Part 2: Discovery of Novel [1,2,4]Triazolo[1,5-a]Pyrimidines Using a Structure-Guided Core-Refining Approach.” European Journal of Medicinal Chemistry, vol. 85, Oct. 2014, pp. 293–303. EBSCOhost, https://doi.org/10.1016/j.ejmech.2014.07.104.
APA
Wang, L., Tian, Y., Chen, W., Liu, H., Zhan, P., Li, D., Liu, H., De Clercq, E., Pannecouque, C., & Liu, X. (2014). Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach. European Journal of Medicinal Chemistry, 85, 293–303. https://doi.org/10.1016/j.ejmech.2014.07.104
Chicago
Wang, Liu, Ye Tian, Wenmin Chen, Hong Liu, Peng Zhan, Dongyue Li, Huiqing Liu, Erik De Clercq, Christophe Pannecouque, and Xinyong Liu. 2014. “Fused Heterocycles Bearing Bridgehead Nitrogen as Potent HIV-1 NNRTIs. Part 2: Discovery of Novel [1,2,4]Triazolo[1,5-a]Pyrimidines Using a Structure-Guided Core-Refining Approach.” European Journal of Medicinal Chemistry 85 (October): 293–303. doi:10.1016/j.ejmech.2014.07.104.